TRIB1AL and hepatoblastoma: We previously showed that the commonly used immortalized hepatocyte-like cell models, namely HepG2 (hepatoblastoma) and HuH-7 (hepatocarcinoma), were largely unresponsive to TRIBAL targeted intervention, specifically TRIBAL overexpression (in HepG2) and TRIBAL suppression (in HuH-7) [14].